Logo-apb
Adv Pharm Bull. 2016;6(4): 479-494. doi: 10.15171/apb.2016.062
PMID: 28101455        PMCID: PMC5241406

Review Article

Pharmaceutical Cocrystals: Regulatory and Strategic Aspects, Design and Development

Dipak Dilip Gadade 1 * , Sanjay Sudhakar Pekamwar 1 * ORCID

Cited by CrossRef: 88


1- Jiang X, Yu K, Nam D, Oh J. A Population Pharmacokinetic Study to Compare a Novel Empagliflozin L-Proline Formulation with Its Conventional Formulation in Healthy Subjects. Pharmaceuticals. 2024;17(4):522 [Crossref]
2- Raut M, Giri L, Pedireddi V. Supramolecular Assemblies of cis,cis,cis‐1,2,4,5‐Cyclohexanetetracarboxylic Acid with Various Aza‐Donors. ChemistrySelect. 2018;3(11):3194 [Crossref]
3- Ai Q, Norquist A, Schrier J. Predicting compositional changes of organic–inorganic hybrid materials with Augmented CycleGAN. Digital Discovery. 2022;1(3):255 [Crossref]
4- Pekamwar S, Kulkarni D. DEVELOPMENT AND EVALUATION OF BICOMPONENT COCRYSTALS OF ACECLOFENAC FOR EFFICIENT DRUG DELIVERY WITH ENHANCED SOLUBILITY AND IMPROVED DISSOLUTION. IND DRU. 2021;58(08):54 [Crossref]
5- Zerrouki K, Bouchene R, Tüzün B, Retailleau P. Novel supramolecular co-crystal of 8-hydroxyquinoline with acetone-(2,4-dinitrophenyl)hydrazone: One pot synthesis, structural characterization, Hirshfeld surface and energy framework analysis, computational investigation and molecular docking study. Journal of Molecular Structure. 2024;1300:137290 [Crossref]
6- Anand R, Kumar A, Nanda A. Pharmaceutical Co-Crystals - Design, Development and Applications. DDL. 2020;10(3):169 [Crossref]
7- Harfouche L, Couvrat N, Sanselme M, Brandel C, Cartigny Y, Petit S, Coquerel G. Discovery of New Proxyphylline-Based Chiral Cocrystals: Solid State Landscape and Dehydration Mechanism. Crystal Growth & Design. 2020;20(6):3842 [Crossref]
8- Ross S, Ward A, Basford P, McAllister M, Douroumis D. Coprocessing of Pharmaceutical Cocrystals for High Quality and Enhanced Physicochemical Stability. Crystal Growth & Design. 2019;19(2):876 [Crossref]
9- Sabouri S, Shayanfar A. Effects of Surfactant and Polymer on Thermodynamic Solubility and Solution Stability of Carbamazepine–Cinnamic Acid Cocrystal. Pharm Chem J. 2022;56(7):913 [Crossref]
10- Zochedh A, Chandran K, Shunmuganarayanan A, Sultan A. Exploring the Synergistic Effect of Tegafur-Syringic Acid Adduct Against Breast Cancer through DFT Computation, Spectroscopy, Pharmacokinetics and Molecular Docking Simulation. Polycyclic Aromatic Compounds. 2024;44(4):2153 [Crossref]
11- Chauhan V, Mardia R, Patel M, Suhagia B, Parmar K. Technical and Formulation Aspects of Pharmaceutical Co‐Crystallization: A Systematic Review. ChemistrySelect. 2022;7(37) [Crossref]
12- Sarkar N, Aakeröy C. Evaluating hydrogen-bond propensity, hydrogen-bond coordination and hydrogen-bond energy as tools for predicting the outcome of attempted co-crystallisations. Supramolecular Chemistry. 2020;32(2):81 [Crossref]
13- Chamorro Orué A, Boese R, Schauerte C, Merz K. An Experimental and Theoretical Approach to Control Salt vs Cocrystal vs Hybrid Formation—Crystal Engineering of an E/Z-Butenedioic Acid/Phthalazine System. Crystal Growth & Design. 2019;19(3):1616 [Crossref]
14- Rana M, Garai A, Nangia A. Cocrystals and Salts of Milrinone with Fluoro Coformers: Improving Drug Dissolution and Diffusion and Calculating Normalized Diffusion for Pharmaceutical Cocrystals. Crystal Growth & Design. 2023;23(9):6461 [Crossref]
15- Prashanth J, Voronin A, Surov A, Balasubramanian S. Design of pyrazine cocrystals of enzalutamide: a lead from 1,4-dioxane solvates. CrystEngComm. 2024;26(28):3851 [Crossref]
16- Diniz L, Franco C, Silva D, Martins L, Carvalho Jr P, Souza M, Reis N, Fernandes C, Diniz R. Multicomponent ionic crystals of diltiazem with dicarboxylic acids toward understanding the structural aspects driving the drug-release. International Journal of Pharmaceutics. 2021;605:120790 [Crossref]
17- Teoh X, bt Mahyuddin F, Ahmad W, Chan S. Formulation strategy of nitrofurantoin: co-crystal or solid dispersion?. Pharmaceutical Development and Technology. 2020;25(2):245 [Crossref]
18- Ngilirabanga J, Rosa P, Aucamp M, Kippie Y, Samsodien H. Dual-drug co-crystal synthesis for synergistic in vitro effect of three key first-line antiretroviral drugs. Journal of Drug Delivery Science and Technology. 2020;60:101958 [Crossref]
19- Gaur R. Polymorphism in parabanic acid-urea cocrystals governed by supramolecular synthons: a comparative analysis. CrystEngComm. 2023;25(33):4680 [Crossref]
20- Hussain E, Kumar R, Choudhary M, Yousuf S. Crystal Engineering of Naturally Occurring Seselin To Obtain Cocrystal with Enhanced Anti-Leishmanial Activity, Hirshfeld Surface Analysis, and Computational Insight. Crystal Growth & Design. 2018;18(8):4628 [Crossref]
21- Zhou H, Duan C, Qin H, Huang C, Hou J, Chen Y, Zhu J, Xu C, Jin J, Zhuang T. Synthesis and structural characterization of a novel palbociclib-kaempferol cocrystal with improved tabletability and synergistic antitumor activity. Journal of Molecular Structure. 2023;1281:135101 [Crossref]
22- Sathisaran I, Skieneh J, Rohani S, Dalvi S. Curcumin Eutectics with Enhanced Dissolution Rates: Binary Phase Diagrams, Characterization, and Dissolution Studies. J Chem Eng Data. 2018;63(10):3652 [Crossref]
23- Tharik A, Meyyanathan S. Recent Patents of Pharmaceutical Co-Crystals: Product Development on Anti-Cancer Drugs and Beyond. PRA. 2023;18(3):246 [Crossref]
24- Sverdlov Arzi R, Sosnik A. Electrohydrodynamic atomization and spray-drying for the production of pure drug nanocrystals and co-crystals. Advanced Drug Delivery Reviews. 2018;131:79 [Crossref]
25- Aitipamula S, Das S. Cocrystal formulations: A case study of topical formulations consisting of ferulic acid cocrystals. European Journal of Pharmaceutics and Biopharmaceutics. 2020;149:95 [Crossref]
26- Zhang X, Xing H, Zhao Y, Ma Z. Pharmaceutical Dispersion Techniques for Dissolution and Bioavailability Enhancement of Poorly Water-Soluble Drugs. Pharmaceutics. 2018;10(3):74 [Crossref]
27- Wróblewska A, Śniechowska J, Kaźmierski S, Wielgus E, Bujacz G, Mlostoń G, Chworos A, Suwara J, Potrzebowski M. Application of 1-Hydroxy-4,5-Dimethyl-Imidazole 3-Oxide as Coformer in Formation of Pharmaceutical Cocrystals. Pharmaceutics. 2020;12(4):359 [Crossref]
28- Stainton P, Nauha E, Grecu T, McCabe J, Munshi T, Scowen I, Chan H, Nilsson S, Blagden N. Chameleon Behavior of a New Salt of 3-(Aminocarbonyl) Pyridinium Malonate and Implications for Polymorphism on the Salt/Cocrystal Continuum. Crystal Growth & Design. 2022;22(3):1665 [Crossref]
29- G